(UroToday.com) Radical prostatectomy (RP) is a standard treatment for patients with localized prostate cancer. A proportion of patients will experience biochemical recurrence following surgery. In these cases, salvage radiotherapy (ideally, early salvage radiotherapy) is indicated. During the plenary abstract presentation in the Prostate Cancer – Advanced Disease Poster Session at the 2021 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium, Dr. Pirus Ghadjar and colleagues report the results of the European SAKK 09/10 randomized Phase III trial comparing the effectiveness and tolerability of conventional vs. dose-intensified salvage radiation therapy (RT).